Advertisement

Research in Experimental Medicine

, Volume 191, Issue 1, pp 137–144 | Cite as

Relationship of eye muscle antibodies with HLA phenotypes and thyroid-stimulating immunoglobulins in endocrine orbitopathy

  • G. Kahaly
  • R. Moncayo
  • C. Stover
  • J. Beyer
Article

Summary

The relationship between endocrine orbitopathy and Graves' hyperthyroidism is still not clairified. The purpose of this study was to elucidate the incidence of eye muscle antibodies and the relationship with HLA phenotypes and thyroid antibodies in 65 patients with endocrine orbitopathy classes 1–5. Both bovine and abdominal muscles were used as antigens in ELISA systems in which IgG and IgM antibodies were assayed. Before starting the immunosuppressant therapy, 46/65 patients (71%) showed a positive result for eye muscle antibodies. Those patients with an active disease had such antibodies more frequently. Where the ophthalmopathy was of recent onset IgM antibodies were found, whereas patients with chronic disease were mostly IgG-Ab positive No association was found either with HLA phenotypes (B8, DR3) or with antibodies directed against thyroglobulin, thyroid microsomes, and the TSH receptor measured as thyroid-stimulating immunoglobulins. Furthermore, there was no correlation between ophthalmopathy class and optic muscle antibody-binding activity. There was no relation between the degree of exophthalmos and eye muscle, thyroid-stimulating, antithyroglobulin, or antithyroid microsomal antibodies. These results suggest that, although very closely related, endocrine orbitopathy and Graves' hyperthyroidism are separate, organ-specific autoimmune diseases.

Key words

HLA phenotypes Eye muscle Thyroid antibodies 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ahman A, Baker JR, Weetman AP, Wartofsky L, Nutman TB, Burman KB (1987) Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 64:454–460Google Scholar
  2. 2.
    Atkinson S, Holcombe M, Kendall-Taylor P (1984) Ophthalmopathic immunoglobulin in patients with Graves' ophthalmopathy. Lancet II:374–376CrossRefGoogle Scholar
  3. 3.
    Bodmer WF, Batchelor JR, Festenstein H, Morris PJ (1978) Histocompatibility testing. Munksgaard, CopenhagenGoogle Scholar
  4. 4.
    Faryna M, Nauman J, Gardas A (1985) Measurement of antibodies against human eye muscle membranes in Graves' ophthalmopathy. Br Med J 290:191–192Google Scholar
  5. 5.
    Feldt-Rasmussen U, Kemp A, Bech K, Madsen SN, Date J (1981) Serum thyroglobulin, its autoantibody and thyroid stimulating antibodies in the endocrine exophthalmos. Acta Endocrinol 96:192–198PubMedGoogle Scholar
  6. 6.
    Forbes G (1984) Computerized imaging evaluation: CT and NMR scanning and computed volume measurement. In: Gorman CA, Waller RR, Dyer JA (eds) The eye and orbit in thyroid disease. Raven Press, New York, pp 173–183Google Scholar
  7. 7.
    Frecker M, Stenszky V, Balasz C, Kozma L, Kraszits E, Farid NR (1986) Genetic factors in Graves' ophthalmopathy. Clin Endocrinol 25:479–485Google Scholar
  8. 8.
    Jacobson DH, Gorman CA (1984) Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis and treatment. Endocrinol Rev 5:200–220CrossRefGoogle Scholar
  9. 9.
    Kadlubowski M, Irvine WJ, Rowland AC (1986) The lack of specificity of ophthalmic immunoglobulins in Graves' disease. J Clin Endocrinol Metab 63:990–995PubMedGoogle Scholar
  10. 10.
    Kendall-Taylor P (1985) The pathogenesis of Graves' ophthalmopathy. Clin Endocrinol Metab 14:331–349PubMedCrossRefGoogle Scholar
  11. 11.
    Kendall-Taylor P, Jones D, Weightman D, Atkinson S (1989) The diagnostic value of antibody tests in Graves' ophthalmopathy. In: Pickardt CR, Boergen KP (eds) Graves' ophthalmopathy. Developments in diagnostic methods and therapeutical procedures. (Developmental ophthalmology, vol 20) Karger, Basel, pp 51–57Google Scholar
  12. 12.
    Kodama K, Sikorska H, Bandy-Dafoe P, Bayly R, Wall JR (1982) Demonstration of a circulating autoantibody against a soluble eye-muscle antigen in Graves' ophthalmopathy. Lancet II:1353–1356CrossRefGoogle Scholar
  13. 13.
    Loeffler M, Zararijas M, McKenzie JM (1983) Comparison of different assays for the thyroid-stimulating antibody of Graves' disease. J Clin Endocrinol Metab 57:603–08PubMedGoogle Scholar
  14. 14.
    Mengistu M, Laryea E, Miller A, Wall JR (1986) Clinical significance of a new autoantibody against a human eye muscle soluble antigen, detected by immunofluoresence. Clin Exp Immunol 65:19–27PubMedGoogle Scholar
  15. 15.
    Moncayo R (1989) Autoimmunity of endocrine ophthalmopathy: immunological characterization of the circulating antibodies and biochemical properties of the isolated soluble eye muscle antigen. In: Lamberg BA, Välimäki, M (eds) Advances in endocrine ophthalmopathy of Graves' Disease. Acta Endocrinol 121 [Suppl 2]:99–106Google Scholar
  16. 16.
    Moncayo R, Pfeiffer EF (1987) Humorale Autoimmunität bei endokriner Ophthalmopathie. In: Beyer J, Kahaly G (eds) Fortschritte in Diagnostik und Therapie der endokrinen Ophthalmopathie. PMI, Frankfurt, pp 72–80Google Scholar
  17. 17.
    Moncayo R, Krisch K, Pasquarello T, Pfeiffer EF (1988) Islet cell antigens. Extraction studies and ELISA analysis. Diabetes 38:1137–1143CrossRefGoogle Scholar
  18. 18.
    Ossoining KC (1984) Ultrasonic diagnosis of Graves' ophthalmopathy. In: Gorman CA, Waller RR, Dyer JA (eds) The eye and orbit in thyroid disease. Raven Press. New York, pp 185–211Google Scholar
  19. 19.
    Salvi M, Hiromatsu Y, Wosu L, Laryea E, How J, Wall JR (1986) Current status of auto-antibodies against orbital antigens in the pathogenesis of Graves' ophthalmopathy. In: Drexhage HA, Wiersinga WM (eds) The thyroid and autoimmunity. Elsevier. Amsterdam, pp 255–266Google Scholar
  20. 20.
    Volpe R (1989) Endocrine Ophthalmopathy. In: Pickardt CR, Boergen KP (eds) Graves' ophthalmopathy. Developments in diagnostic methods and therapeutical procedures. (Developmental ophthalmology, vol 20) Karger. Basel, pp 213–226Google Scholar
  21. 21.
    Waller RR, Jacobson DH (1984) Endocrine ophthalmopathy: differential diagnosis. In: Gorman CA, Waller RR, Dyer JA (eds) The eye and orbit in thyroid disease. Raven Press, New York, pp 185–211Google Scholar
  22. 22.
    Weetman AP, So AK, Warner CA, Foroni L, Fells P, Shine B (1988) Immunogenetics of Graves' ophthalmopathy. Clin Endocrinol 28:619–628Google Scholar
  23. 23.
    Werner SC (1977) Modification of the classification of the eye changes of Graves' disease: recommendation of the ad hoc committee of the American Thyroid Association. J Clin Endocrinol Metab 44:203–204PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • G. Kahaly
    • 1
  • R. Moncayo
    • 2
  • C. Stover
    • 1
  • J. Beyer
    • 1
  1. 1.III. Department of Medicine, Endocrinology and MetabolismJohannes Gutenberg-University HospitalMainzFederal Republic of Germany
  2. 2.Institute for Hormone ResearchHamburgFederal Republic of Germany

Personalised recommendations